Cy­bin gears up for reg­is­tra­tional tri­al of psilo­cy­bin ana­log in ma­jor de­pres­sion af­ter PhII suc­cess

Cy­bin’s psy­che­del­ic-in­spired drug can­di­date has met the pri­ma­ry end­point of its mid-stage test in ma­jor de­pres­sive dis­or­der (MDD), spark­ing prepa­ra­tions for a Phase III tri­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER